In conclusion, our results reveal that DNM3OS is upregulated in httex1p‐Q74 cells and the DNM3OS/miR‐196b‐5p/GAPDH axis is involved in regulating biological behaviour and IB formation of the mHtt protein, which may offer a potential therapeutic strategy for HD. Here, GAPDH is linked to Huntington disease.